Studies on the mechanism of thrombosis formation in hypoalbuminemia and hyperlipidemia.
Studies on the mechanism of thrombosis formation in hypoalbuminemia and hyperlipidemia.
批准号:
62480434
负责人:
OKABE Hiroaki
金额:
$4.35万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1987
资助国家:
日本
项目状态:
已结题
起止时间:
1987 至 1988
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Thrombotic diseases are increasing recently. Among the various dsisease states, thrombotic episodes have been known to associate frequently with nephrotic syndrome which is characterized by hyperlipidemia and hypoalbuminemia. However, mechanism by which thrombus can be formed in this syndrome remains to be clarified. To elucidate the mechanism of thrombus formation under hypoalbuminemia and hyperlipidemia, coagulation and fibrinolytic states were characterized in Nagase analbuminemia rats (NAR) which reveals the patological condtions similar to nephrotic syndrome; i.e.analubuminemia and hyperlipidemia.1. Anti human facotor Xa (FXa) activity was found in plasma of nar and Sprague-Dawrey rats (SDR), the value of which was found to be 2-3 times higher in nar than that in SDR. Although the plasma component responsible for the anti human F-Xa activity has not yet been fully identified, alpha2-macroglobulin may be possibly one of good candidates. Plasma levels of antithrombin III (at III) an … More d alpha2-plasmin inhibitor were higher in NAR than those in SDR.2. When endotoxin was administered to NAR and SDR, mortality was significantly higher in NAR than that in SDR (30 % vs 0 %, respectively). Based on the findings of the changes in coagulation and fibrinolysis of these experimental DIC animals, severer DIC was induced in NAR than in SDR.3. When thrombus was induced in the small mesenteric artery of rats by inserting the microglass pipette, thrombus was formed within 4-5 min of insertion in both animals. Thrombus thus formed gradually grew up in its size to dissociate from the glasspipette and vascular wall and flew away into circulation. Thrombus was disappeared in such a way within 3-4 min of the thrombus formation in SDR, whereas thrombus was disappeared at 12-15 min of the formation in NAR and the maximum size of thrombus was 3 times bigger in NAR than that in SDR.These findings suggested that NAR might be sensitive to the stimuli causing to the thrombus formation and , thus, hypoalbuminemia and hyperlipidemia per se might be the risk factors for the thrombus formation. Less
期刊论文(47)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Hiroaki,Okabe: "Further studies on the resolution of human mercapto- and nonmercaptoalbumin and on human serum albumin in the elderly by high performance liquid chromatography." Int. J. Peptide Protein Res.31. 435-442 (1988)
Hiroaki,Okabe:“通过高效液相色谱法对人巯基和非巯基白蛋白以及老年人血清白蛋白的分离进行进一步研究。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masayasu Inoue: Biochem.Pharmacol.36. 2145-2150 (1987)
井上雅康:Biochem.Pharmacol.36。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kenji,Okajima: "Characterization of fibrinolytic state by measuring stable crosslinked degradation products in disseminated intravascular coagulation" Acta Haematologica. (1989)
Kenji,Okajima:“通过测量弥散性血管内凝血中稳定的交联降解产物来表征纤溶状态”Acta Haematologica。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 19 条
Research of analytical methods for infection test by capillary electrophoresis.
-
批准号:11672299
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:OKABE Hiroaki
-
依托单位:
Development of analytical methods by capillary electophoresis for human fluids.
-
批准号:06672296
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1994
-
负责人:OKABE Hiroaki
-
依托单位:
Evaluation Of Clinical Laboratory Test By Using Quartz Crystal Resonator
-
批准号:04671437
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1992
-
负责人:OKABE Hiroaki
-
依托单位:
Proteolytic Measurement of Isoenzymes in Blood
-
批准号:01480506
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$2.62万
-
财政年份:1989
-
负责人:OKABE Hiroaki
-
依托单位:
海外基金